Safety Evaluation of Cytoreductive Surgery for Colorectal Peritoneal Metastases

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1030230662

Enrollment

Registered

2024-02-27

Start date

2024-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Peritoneal metastases

Interventions

Cytoreductive Surgery

Cytoreduction Surgical Procedures

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Histologically confirmed colorectal adenocarcinoma Clinical diagnosis of colorectal peritoneal metastases Peritoneal cancer index no more than 20 Peritoneal disease within surgically removable range Age between 20 and 75 years old ECOG performance status of 0 or 1 Written informed consent with sufficient understanding

Exclusion criteria

Exclusion criteria: Uncontrollable distant metastases Inability to endure cytoreductive surgery under general anesthesia Coagulation abnormalities Psychiatric impairment Pregnancy, possible pregnancy, or breastfeeding

Design outcomes

Primary

Measure	Time frame
Incidence of severe perioperative adverse event (Clavien-Dindo Grade 3)	—

Secondary

Measure	Time frame
Incidence of perioperative adverse events, Incidence of intraoperative adverse events, Percentage of complete removable of visible peritoneal disease, Overall survival, Relapse-free survival	—

Contacts

Public ContactHiroshi Nagata

National Cancer Center Hospital

hinaga2@ncc.go.jp+81-3-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026